I was diagnosed more than ten years ago at the ripe old age of thirty-eight (yeah, ancient, I know). Since that diagnosis, several things have come along that grabbed the spotlight for a few days, but nothing has actually been substantiated in clinical trials as an effective solution to this insidious disease.
People are affected differently by Parkinson's Disease. I don't have much of a tremor, but I have a pronounced stutter (pun intended), a shuffling gait, a twitching countenance, an impressive drool at times (especially while I am sleeping), loss of flexibility, "freezing" while trying to walk, and a sense of balance that would not do well in the Olympics. I know what you're thinking. My, what glamorous symptoms these are.
Perhaps the most significant impact on me has been cognitive impairment in the "executive functioning" portion of my brain. That is, my organizational skills; my problem solving abilities; and my attention to detail and logistics are all suffering. That has not boded well for my career in software development. I have worked in that field for the past twenty-five years and recently discovered I can no longer "get it done." It's terribly frustrating to realize that something I used to do (with great success) is now beyond my reach.
There is always hope, of course, and now it looks as if the potential for a cure (or a fix, if you prefer) could be just around the corner. Gene therapy has looked promising for several diseases, and in recent years some research involving gene therapy and Parkinson's Disease has been done. Over the past three years, a clinical trial of CERE-120 was held (gene therapy involving the injection of a virus in the brain), and though some of the participants of the study reported experiencing improvement in their symptoms, the data in the double blind study did not hold up. Investigation by scientists led the medical community to believe that perhaps not enough of this drug was used and that it was not injected deep enough in the brain.
A new study of CERE-120 has begun, and the same drug will be used again. This time, though, much more of it will be injected into the brain, and the injections will be deep, actually in the part of the brain where the dopamine-producing neurons live. I am fortunate and blessed to be part of it. I am participating in Phase 1, the "safety and efficacy" phase, and I am the third person who will have had this done. Six people will go through Phase 1 during a six month (or longer) period. If it is shown to be safe and reasonable, then Phase 2 will open up with a double blind study of fifty-eight people.
Is this going to work? We don't know. But in laboratory animals, the dopamine-producing neurons that have "died" and / or are dormant have actually been restored. If this works in humans, it would be the first time that the disease can be addressed and not just the symptoms.
Keep in mind that when a person is diagnosed with Parkinson's Disease, he or she has already lost eighty percent or more of the dopamine-producing neurons that are used for movement. Restoring some or most of those neurons could actually reverse the damaging effects of the disease.
Now that would be cool.
Assuming everything progresses as planned, I will be having brain surgery on Tuesday, March 2nd, 2010. That's less than three days away from now, as I sit and write this. Two one-inch holes will be drilled in my head, and a series of injections reaching down to the substantia nigra (where the bulk of these neurons reside) will be done.
How will my body respond? I don't know.
Will my cognitive abilities return? I don't know.
The surgeon says it could be many months before any benefit is realized. It could be longer.
But we're trying. The medical community has come a long ways since the mid-1970s, when I watched my grandmother wither away from the ravages of both the disease and the massive amount of medication the doctors pumped into her.
Are there risks with the surgery and the virus? Sure there are. But there's a chance it will work. And boy, am I ready for Joel Revision II to be released.
Published by nutuba
I have just published my second book! To find out more about Off Balance: Getting Back Up When Life Knocks You Down, visit www.GennesaretPress.com. My first book, I Laid an Egg on Aunt Ruth's Head, continues... View profile
What is a Double Blind Test? A Psychological Testing TermA general look at scientific experiments and what a double-blind test is by looking through the lens of a psychologist.- Researchers Find the Chemical that Causes Parkinson's DiseaseParkinson's disease affects millions of Americans. In groundbreaking research, researchers announced that they have identified the actual chemical that causes Parkinson's disease. This should lead to new treatments, a...
FDA Approves Neupro Patch for Parkinson's DiseaseParkinson's is a debilitating illness that results from the loss of dopamine- producing brain cells. The Neupro Patch contains rotigotine, which belongs to the dopamine agonist...- Ovarian Cancer: Diagnosis & Treatment Including Gene TherapyOvarian cancer is a malignant tumor, develops in the ovaries. Methods available to detect & confirm this cancer. Available are various treatments, depending on the extent of the cancer growth. Gene therapy completely/...
- In Defense of Somatic Gene TherapyIn favor of the necessity of somatic gene therapy based on the expression of autonomy and beneficence.
- Parkinson's Disease- Symptoms, Treatments, and Perhaps Some Hope
- Facts and Figures About Parkinson's Disease
- Azilect, a Synopsis of Parkinson's Disease Treatment Option
- History and Treatment of Parkinson's Disease
- Omega 3 Fatty Acids Could Prevent Parkinson's Disease
- Parkinson's Disease: Tips for Sufferers
- New Advances in the Treatment of Parkinson's Disease
